As cracks begin to appear in the U.S. exceptionalism narrative, investors are learning that ignoring other investment ...

LONDON, GB / ACCESS Newswire / February 20, 2025 / Birkenstock Holding plc ("BIRKENSTOCK", the "Company" or "we"), today announces financial results for the first quarter ended December 31, ...

During the company's opening remarks, all participants will be in a listen-only mode. Following the opening remarks, we will ...

Many fans of Doylestown-native singer Pink assume her stage name stems from the hair color she wore early in her career, but ...

NEW YORK CITY, NY / ACCESS Newswire / February 19, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law ...

LONDON, GB / ACCESS Newswire / February 20, 2025 / Birkenstock Holding plc ("BIRKENSTOCK", the "Company" or "we"), (NYSE:BIRK) today announces financial results for the first quarter ended December 31 ...

First Half-Year Results Earnings Conference Call February 19, 2025 6:30 PM ETCompany ParticipantsGraham Chipchase ...

Helen Torley; President, Chief Executive Officer, Director; Halozyme Therapeutics Inc Nicole Labrosse; Chief Financial Officer, Senior Vice President; Halozyme Therapeutics Inc Good afternoon. My name ...

Press Gazette analysis of news and current affairs magazine ABCs for 2024. Prospect digital growth more than offsets print ...

Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) and Sobi ® (STO:SOBI) today announced the European Medicines Agency (EMA) has validated an indication extension application for Aspaveli ® (pegcetacoplan) ...

Adj. EBITDA guidance of $100-$170 millionPosted adjusted EBITDA of $153.8 million for the full year 2024 and $9.8 million for ...